CytomX Therapeutics
CTMX
CTMX
81 hedge funds and large institutions have $57.2M invested in CytomX Therapeutics in 2022 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 20 increasing their positions, 21 reducing their positions, and 15 closing their positions.
Holders
81
Holders Change
-2
Holders Change %
-2.41%
% of All Funds
1.31%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
20
Reduced
21
Closed
15
Calls
$56K
Puts
$54K
Net Calls
+$2K
Net Calls Change
-$28K
Top Buyers
1 |
1
Millennium Management
New York
|
$2.75M |
2 |
2
Citadel Advisors
Miami,
Florida
|
$733K |
3 |
3
Two Sigma Investments
New York
|
$1.19M |
4 |
TC
4
Tejara Capital
London,
United Kingdom
|
$378K |
5 |
5
D.E. Shaw & Co
New York
|
$989K |